Related Experiment Video
Updated: Mar 8, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Age Related Multiple Sclerosis Severity Score: Disability ranked by age
Ali Manouchehrinia1, Helga Westerlind2, Elaine Kingwell3
1Department of Clinical Neuroscience (CNS), Karolinska Institutet, Stockholm, Sweden.
The Age Related Multiple Sclerosis Severity (ARMSS) score, using patient age, offers a comparable alternative to the Multiple Sclerosis Severity Score (MSSS), which uses disease duration. ARMSS may reduce study bias and improve statistical power.
Area of Science:
- Neurology
- Clinical Research
- Biostatistics
Background:
- The Multiple Sclerosis Severity Score (MSSS) normalizes the Expanded Disability Status Scale (EDSS) for disease duration, proving useful in cross-sectional studies.
- Disease duration can be ambiguous, potentially introducing bias and affecting study power.
Purpose of the Study:
- To evaluate the feasibility of using patient age instead of disease duration for a Multiple Sclerosis (MS) severity score.
- To develop and validate an Age Related Multiple Sclerosis Severity (ARMSS) score.
Main Methods:
- Pooled disability data from 26,058 patients across three population-based cohorts (Sweden, Canada, UK).
- Developed the ARMSS score by ranking EDSS scores based on patient age at assessment.
- Assessed the ARMSS score's power to detect group differences and its consistency over time.
Main Results:
- Moderate correlations were observed between EDSS and disease duration (r=0.46) and between EDSS and age (r=0.44).
- The ARMSS score demonstrated comparable statistical power to detect disability differences between groups as the MSSS.
- The ARMSS score showed good consistency over time.
Conclusions:
- Age is a more objective and readily available metric than disease duration for MS severity scoring.
- The ARMSS score is a viable and potentially more versatile alternative to the MSSS.
- ARMSS can minimize study biases and power loss associated with inaccurate or missing disease onset data.
More Related Videos
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
06:49A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
Published on: October 6, 2015